267 related articles for article (PubMed ID: 19720831)
21. Inhibition of gluconeogenesis through transcriptional activation of EGR1 and DUSP4 by AMP-activated kinase.
Berasi SP; Huard C; Li D; Shih HH; Sun Y; Zhong W; Paulsen JE; Brown EL; Gimeno RE; Martinez RV
J Biol Chem; 2006 Sep; 281(37):27167-77. PubMed ID: 16849326
[TBL] [Abstract][Full Text] [Related]
22. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes.
Chanda D; Kim DK; Li T; Kim YH; Koo SH; Lee CH; Chiang JY; Choi HS
J Biol Chem; 2011 Aug; 286(32):27971-9. PubMed ID: 21693703
[TBL] [Abstract][Full Text] [Related]
24. Phosphoenolpyruvate carboxykinase and glucose-6-phosphatase are required for steroidogenesis in testicular Leydig cells.
Ahn SW; Gang GT; Tadi S; Nedumaran B; Kim YD; Park JH; Kweon GR; Koo SH; Lee K; Ahn RS; Yim YH; Lee CH; Harris RA; Choi HS
J Biol Chem; 2012 Dec; 287(50):41875-87. PubMed ID: 23074219
[TBL] [Abstract][Full Text] [Related]
25. CREB-upregulated lncRNA MEG3 promotes hepatic gluconeogenesis by regulating miR-302a-3p-CRTC2 axis.
Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W; Kang D; Ye S
J Cell Biochem; 2019 Mar; 120(3):4192-4202. PubMed ID: 30260029
[TBL] [Abstract][Full Text] [Related]
26. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
27. The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4α and FOXO1 transcriptional activity.
Yarushkin AA; Kachaylo EM; Pustylnyak VO
Br J Pharmacol; 2013 Apr; 168(8):1923-32. PubMed ID: 23231652
[TBL] [Abstract][Full Text] [Related]
28. Metformin inhibits growth hormone-mediated hepatic PDK4 gene expression through induction of orphan nuclear receptor small heterodimer partner.
Kim YD; Kim YH; Tadi S; Yu JH; Yim YH; Jeoung NH; Shong M; Hennighausen L; Harris RA; Lee IK; Lee CH; Choi HS
Diabetes; 2012 Oct; 61(10):2484-94. PubMed ID: 22698918
[TBL] [Abstract][Full Text] [Related]
29. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
30. Novel concepts in insulin regulation of hepatic gluconeogenesis.
Barthel A; Schmoll D
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E685-92. PubMed ID: 12959935
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition.
Renga B; Mencarelli A; D'Amore C; Cipriani S; Baldelli F; Zampella A; Distrutti E; Fiorucci S
FASEB J; 2012 Jul; 26(7):3021-31. PubMed ID: 22447981
[TBL] [Abstract][Full Text] [Related]
32. Orphan nuclear receptor SHP interacts with and represses hepatocyte nuclear factor-6 (HNF-6) transactivation.
Lee YS; Kim DK; Kim YD; Park KC; Shong M; Seong HA; Ha HJ; Choi HS
Biochem J; 2008 Aug; 413(3):559-69. PubMed ID: 18459945
[TBL] [Abstract][Full Text] [Related]
33. Progesterone increases blood glucose via hepatic progesterone receptor membrane component 1 under limited or impaired action of insulin.
Lee SR; Choi WY; Heo JH; Huh J; Kim G; Lee KP; Kwun HJ; Shin HJ; Baek IJ; Hong EJ
Sci Rep; 2020 Oct; 10(1):16316. PubMed ID: 33005004
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway.
Liu HY; Wen GB; Han J; Hong T; Zhuo D; Liu Z; Cao W
J Biol Chem; 2008 Nov; 283(45):30642-9. PubMed ID: 18786922
[TBL] [Abstract][Full Text] [Related]
35. Vernonia amygdalina Delile extract inhibits the hepatic gluconeogenesis through the activation of adenosine-5'monophosph kinase.
Wu XM; Ren T; Liu JF; Liu YJ; Yang LC; Jin X
Biomed Pharmacother; 2018 Jul; 103():1384-1391. PubMed ID: 29864922
[TBL] [Abstract][Full Text] [Related]
36. MiR-19a mediates gluconeogenesis by targeting PTEN in hepatocytes.
Dou L; Wang S; Huang X; Sun X; Zhang Y; Shen T; Guo J; Man Y; Tang W; Li J
Mol Med Rep; 2018 Mar; 17(3):3967-3971. PubMed ID: 29257352
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Sodium-Glucose Cotransporter-2 during Serum Deprivation Increases Hepatic Gluconeogenesis via the AMPK/AKT/FOXO Signaling Pathway.
Lee J; Hong SW; Kim MJ; Lim YM; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
Endocrinol Metab (Seoul); 2024 Feb; 39(1):98-108. PubMed ID: 38171209
[TBL] [Abstract][Full Text] [Related]
38. B-cell translocation gene-2 increases hepatic gluconeogenesis via induction of CREB.
Hwang SL; Kwon O; Lee SJ; Roh SS; Kim YD; Choi JH
Biochem Biophys Res Commun; 2012 Nov; 427(4):801-5. PubMed ID: 23058912
[TBL] [Abstract][Full Text] [Related]
39. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
[TBL] [Abstract][Full Text] [Related]
40. The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes.
Lee JM; Han HS; Jung YS; Harris RA; Koo SH; Choi HS
J Biol Chem; 2018 Aug; 293(34):13125-13133. PubMed ID: 29950523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
